Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-013351
Filing Date
2024-12-04
Accepted
2024-12-04 11:36:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27698
2 filename2.txt TEXT-EXTRACT 1181
  Complete submission text file 0000000000-24-013351.txt   40372
Mailing Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE BCM-A, MS: BCM251 HOUSTON TX 77021 (713) 400-6400
Marker Therapeutics, Inc. (Filed for) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-283512
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)